BestMind Behavioral Health

What BestMind Behavioral Health does

BestMind Behavioral Health is a private outpatient psychiatric practice operating 9 clinic locations across Oregon (7) and Washington (2), supplemented by statewide telehealth coverage. The company specializes in treatment-resistant depression, with a clinical portfolio that includes standard Transcranial Magnetic Stimulation (TMS), Accelerated TMS using the Stanford-developed SAINT protocol, Esketamine (SPRAVATO) nasal spray therapy administered at its REMS-certified facility, FDA-cleared TMS for adolescents aged 15 and older, QbTest computer-based ADHD assessment, psychiatric medication management, and telemedicine. Care is delivered by a team of 25 or more board-certified psychiatrists, physician assistants, and psychiatric mental health nurse practitioners, anchored by Medical Director Robert Olsen, MD.

The company's technology stack is built on FDA-cleared and FDA-approved third-party medical devices and pharmaceuticals rather than proprietary software platforms. TMS systems deliver MRI-strength magnetic pulses; the Esketamine program operates under a REMS (Risk Evaluation and Mitigation Strategy) certification; and the QbTest platform combines a computer-based attention/impulsivity task with motion-tracking camera input. Patient-facing infrastructure includes online self-scheduling, a telemedicine platform, and a patient portal (powered by AdvancedMD), but the company has no disclosed AI/ML capabilities or proprietary data assets.

BestMind generates revenue primarily through insurance reimbursement for psychiatric services, accepting most major plans including Aetna, Anthem, Cigna, Humana, United Healthcare, Kaiser Permanente, Providence, PacificSource, Premera, Regence, and Tricare. The revenue model combines one-time diagnostic fees (psychiatric evaluations, ADHD testing) with multi-week recurring treatment courses (36 TMS sessions over 6-9 weeks; twice-weekly Spravato induction). Go-to-market combines direct-to-patient acquisition via organic search, content marketing, and self-serve booking with a formalized healthcare provider referral channel that promises patients seen within 3-4 business days. The customer base is fully individual consumers with no disclosed enterprise clients, and the company explicitly serves treatment-resistant cases referred from primary care physicians and therapists across the Pacific Northwest.

Name

BestMind Behavioral Health

Legal name

BestMind Behavioral Health

Website

https://bestmindbh.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

BestMind Behavioral Health is a Pacific Northwest outpatient psychiatric practice operating 9 clinics in Oregon and Washington plus statewide telehealth. It specializes in treatment-resistant depression using TMS, Esketamine, ADHD testing, and medication management for individual patients.

Ownership category

akta.pro rank

Product category

Behavioral Health Services

NAICS

Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Psychiatry & Medication Management Platforms (HLALAEAB)

akta.pro secondary industry

General Mental Health Therapy Platforms (Talk Therapy) (HLALAEAA)

Keywords

• Mental health treatment
• Psychiatric evaluation services
• Transcranial magnetic stimulation
• ADHD diagnostic testing
• Medication management services

Headquarters

HQ city

Clackamas

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Mental Health Treatment Services: Healthcare services revenue generated from psychiatric evaluations, medication management, TMS therapy, Esketamine treatment, and ADHD testing. Services are primarily covered by patient insurance plans including Aetna, Anthem, Cigna, Humana, United Healthcare, Kaiser Permanente, Providence Health Plan, and PacificSource. Revenue collection occurs through insurance reimbursement with patient responsibility for copays, coinsurance, and deductibles.
2. Insurance Verification Services: Free insurance verification process to help patients understand their benefits coverage before treatment begins. No obligation to either BestMind or insurance provider.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

BestMind Behavioral Health operates a multi-site behavioral health practice delivering psychiatric evaluation, medication management, and advanced interventional treatments such as Transcranial Magnetic Stimulation (TMS, including the Accelerated SAINT protocol), Esketamine (SPRAVATO), and QbTest-based ADHD assessment across Oregon and Washington. Services are provided in person at 9 clinic locations and statewide via telehealth, with most major insurance plans accepted and new patient appointments typically available within 48 hours.

Product overview

BestMind Behavioral Health operates as a behavioral and mental health treatment platform offering a unified suite of psychiatric services across in-person clinic locations in Oregon and Washington plus statewide telehealth options. The core portfolio centers on depression treatment specialists with multiple advanced modalities: TMS Therapy (standard, teen-specific, and Accelerated SAINT protocols), Esketamine (SPRAVATO®) nasal spray therapy, ADHD Testing via QbTest assessment, Medication Management, and Telemedicine. All services are delivered by board-certified psychiatrists, physician assistants, and nurse practitioners, with treatment plans personalized to individual patient needs.

Differentiator

Problem solved

Functional benefit

Products and services

• TMS Therapy FDA-approved non-invasive depression treatment that delivers MRI-strength magnetic pulses to brain regions responsible for mood regulation; 36 sessions over 6-9 weeks for adults with treatment-resistant depression.
• TMS Therapy for Teens FDA-cleared Transcranial Magnetic Stimulation for adolescents aged 15+ with depression, offering a non-drug treatment option with reported 44% remission in clinical trials.
• Accelerated TMS (SAINT Protocol) Accelerated Transcranial Magnetic Stimulation based on the Stanford SAINT protocol that condenses the standard 6-week course into 3-5 days for adults with treatment-resistant depression.
• Esketamine (SPRAVATO) Treatment FDA-approved esketamine nasal spray therapy for treatment-resistant depression targeting NMDA receptors; administered twice weekly initially under direct medical supervision at a REMS-certified facility, then tapered to weekly maintenance.
• Medication Management Ongoing psychiatric medication management including initial evaluation, medication selection and initiation, dose optimization, side-effect management, and regular follow-up visits with a licensed provider.
• Psychiatric Evaluation Comprehensive 60-90 minute psychiatric diagnostic evaluation for new patients, including clinical interview, mental status examination, risk assessment, treatment plan development, and detailed written report.
• ADHD Testing 2-3 hour comprehensive ADHD diagnostic evaluation using QbTest computer-based assessment for attention, impulsivity, and hyperactivity, combined with clinical interview, standardized rating scales (Conners, BAARS), cognitive testing when indicated, and a detailed diagnostic report.
• Telemedicine Virtual psychiatric appointments delivered via secure video for medication management and consultations across Oregon and Washington, covered by most major insurance plans including Aetna, Humana, and United Healthcare.

Quantifiable outcome

• 72.99% response rate; 51.38% remission rate for TMS therapy
• +5 more outcomes

Named customers8 records

Segments8 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators11 records

Recent moves8 records

Expansion highlights5 records

Emerging players

• Talkiatry: Tech-enabled psychiatry group offering in-network psychiatric evaluations and medication management via telehealth and in-person visits. Comparable to BestMind's medication management and psychiatric evaluation services but lacks BestMind's advanced interventional modalities (TMS, Spravato).
• Cerebral: Online mental health subscription platform offering medication management and therapy for anxiety, depression, and ADHD. Comparable in the mental health and ADHD testing/medication management space but pure-play digital versus BestMind's physical-clinic-anchored model.
• Brightside Health: Telepsychiatry and online therapy platform focused on depression and anxiety treatment with medication and therapy services. Comparable target demographic (depression/anxiety patients) but telehealth-only versus BestMind's hybrid clinic + telehealth model.
• PsychoGenics / TMS Solutions: Regional and emerging TMS clinic operators that compete for treatment-resistant depression patients. Comparable as specialty interventional psychiatry providers; many smaller regional TMS clinics overlap with BestMind's service mix in select markets.

Direct peers

• MindPath Health: Outpatient mental health provider with psychiatric evaluations, therapy, medication management, and TMS across multiple states. Closely comparable to BestMind in service mix, multi-state clinic model, and insurance-driven revenue model.
• LifeStance Health: Large publicly-traded outpatient mental health platform offering psychiatric evaluations, medication management, and therapy across 30+ states. Comparable as a multi-state mental health provider scaling via clinic density and in-network insurance contracts, with broader scope than BestMind.
• Greenbrook TMS: Greenbrook operates one of the largest U.S. networks of TMS treatment centers for depression and OCD. Directly comparable to BestMind as a TMS-focused mental health provider with multi-state physical clinic footprint and insurance-reimbursed treatment model.

Broad incumbents

• Acadia Healthcare: Large publicly-traded behavioral healthcare operator running psychiatric hospitals, residential treatment, and outpatient clinics nationwide. Comparable as a behavioral health provider serving serious mental illness but operates at vastly larger scale and includes inpatient services BestMind does not offer.

Others

• NeuroStar (Neuronetics): Neuronetics manufactures the NeuroStar TMS device used by BestMind and many other TMS providers. Adjacent as the upstream device manufacturer enabling BestMind's TMS service line and shaping protocol evolution.
• Headway: Provider network and software platform that helps mental health clinicians accept insurance and build practices. Functionally adjacent to BestMind as an enabler for in-network mental health providers; not a direct competitor but competes for the same clinician supply pool.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/BestMindBH
• LinkedInlinkedin.com/company/bestmindbh
• Instagraminstagram.com/bestmindbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BestMind Behavioral Health